MDT

96.57

+0.48%↑

A

137.03

-0.47%↓

VEEV

224.3

+0.29%↑

HQY

92.65

+0.14%↑

PHR.US

16.89

-1.63%↓

MDT

96.57

+0.48%↑

A

137.03

-0.47%↓

VEEV

224.3

+0.29%↑

HQY

92.65

+0.14%↑

PHR.US

16.89

-1.63%↓

MDT

96.57

+0.48%↑

A

137.03

-0.47%↓

VEEV

224.3

+0.29%↑

HQY

92.65

+0.14%↑

PHR.US

16.89

-1.63%↓

MDT

96.57

+0.48%↑

A

137.03

-0.47%↓

VEEV

224.3

+0.29%↑

HQY

92.65

+0.14%↑

PHR.US

16.89

-1.63%↓

MDT

96.57

+0.48%↑

A

137.03

-0.47%↓

VEEV

224.3

+0.29%↑

HQY

92.65

+0.14%↑

PHR.US

16.89

-1.63%↓

Search

Penumbra Inc

Deschisă

SectorSănătate

315.09 0.27

Rezumat

Modificarea prețului

24h

Curent

Minim

312.02

Maxim

316.03

Indicatori cheie

By Trading Economics

Venit

581K

46M

Vânzări

15M

355M

P/E

Medie Sector

76.393

78.892

Marjă de profit

12.927

Angajați

4,500

EBITDA

4M

55M

Recomandări

By TipRanks

Recomandări

Puternic Cumpărare

Prognoză pe 12 luni

+6.63% upside

Statistici piață

By TradingEconomics

Capitalizare de piață

3.7B

13B

Deschiderea anterioară

314.82

Închiderea anterioară

315.09

Sentimentul știrilor

By Acuity

50%

50%

149 / 374 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Bearish Evidence

Penumbra Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

29 dec. 2025, 22:03 UTC

Principalele dinamici ale pieței

Mining Stocks Slip Near the End of Stellar Year

29 dec. 2025, 15:57 UTC

Principalele dinamici ale pieței

Praxis Shares Rise on Ulixacaltamide Breakthrough Designation

29 dec. 2025, 23:43 UTC

Market Talk

Nikkei May Decline; Yen in Focus -- Market Talk

29 dec. 2025, 23:38 UTC

Achiziții, Fuziuni, Preluări

Manus: Will Continue to Operate From Singapore

29 dec. 2025, 23:38 UTC

Achiziții, Fuziuni, Preluări

Manus: Will Continue to Sell, Operate Product Subscription Service Through App, Website

29 dec. 2025, 23:37 UTC

Achiziții, Fuziuni, Preluări

Meta Platforms: Will Integrate Manus Service Into Products

29 dec. 2025, 23:36 UTC

Achiziții, Fuziuni, Preluări

Meta Platforms: Will Continue to Operate, Sell Manus Service

29 dec. 2025, 23:36 UTC

Achiziții, Fuziuni, Preluări

Meta Platforms: Manus's Talent to Join Team to Deliver General-Purpose Agents Across Consumer, Business Products

29 dec. 2025, 23:35 UTC

Achiziții, Fuziuni, Preluări

Manus to Join Meta Platforms

29 dec. 2025, 21:33 UTC

Achiziții, Fuziuni, Preluări

Origin: Raise Values Kraken at US$8.65 Billion

29 dec. 2025, 21:33 UTC

Achiziții, Fuziuni, Preluări

Origin: Octopus Targeting Kraken Separation by Mid 2026

29 dec. 2025, 21:31 UTC

Achiziții, Fuziuni, Preluări

BlueScope: Rezoning Will Allow for Range of Commercial, Industrial Development Uses

29 dec. 2025, 21:31 UTC

Achiziții, Fuziuni, Preluări

BlueScope Also Says Land Adjacent to Port Kembla Steelworks Rezoned to Special Purpose

29 dec. 2025, 21:30 UTC

Achiziții, Fuziuni, Preluări

Origin's Kraken Stake to Remain at 22.7%

29 dec. 2025, 21:30 UTC

Achiziții, Fuziuni, Preluări

Origin Will Continue to Hold Its 22.7% Interest in Octopus

29 dec. 2025, 21:30 UTC

Achiziții, Fuziuni, Preluări

BlueScope: Guidance Reflects Sustained Strength of Operating Performance in Recent Months

29 dec. 2025, 21:30 UTC

Achiziții, Fuziuni, Preluări

Origin: Additional Interest Offsets Dilution From Raise

29 dec. 2025, 21:30 UTC

Achiziții, Fuziuni, Preluări

BlueScope Doesn't Expect Material Impact on 1H Guidance Range

29 dec. 2025, 21:29 UTC

Achiziții, Fuziuni, Preluări

Origin Waiving Australia Exclusivity to Kraken in Exchange for Additional 1.5% Equity Interest

29 dec. 2025, 21:29 UTC

Achiziții, Fuziuni, Preluări

BlueScope Expects to Complete Property Sale for A$76 Million Consideration

29 dec. 2025, 21:29 UTC

Achiziții, Fuziuni, Preluări

BlueScope Expects to Complete Property Sale in 2H of FY 2026

29 dec. 2025, 21:28 UTC

Achiziții, Fuziuni, Preluări

BlueScope: Selling Residentially Zoned Land in West Dapto to Large Homebuilder

29 dec. 2025, 21:28 UTC

Achiziții, Fuziuni, Preluări

Origin: Kraken's Raise Paves Way for Separation From Octopus Energy

29 dec. 2025, 21:28 UTC

Achiziții, Fuziuni, Preluări

Origin: Kraken to Raise Total US$1 Billion From New, Existing Investors

29 dec. 2025, 21:28 UTC

Achiziții, Fuziuni, Preluări

BlueScope Steel Exchanges Contracts for Sale of 33 Hectares of Land in West Dapto

29 dec. 2025, 21:27 UTC

Achiziții, Fuziuni, Preluări

Origin Energy to Invest US$140M in Kraken's Standalone Equity Raise

29 dec. 2025, 20:22 UTC

Market Talk

Oil Rebounds As Russia-Ukraine War Seen Continuing -- Market Talk

29 dec. 2025, 20:14 UTC

Market Talk

U.S. Natural Gas Futures Rise As Front Month Expires -- Market Talk

29 dec. 2025, 20:02 UTC

Achiziții, Fuziuni, Preluări

Union Pacific--Norfolk Southern Merger Targets Trucking Market Share -- Barrons.com

29 dec. 2025, 17:36 UTC

Market Talk

U.S. Natural Gas Inventories Swing to Deficit Vs. 5-Year Average -- Market Talk

Comparație

Modificare preț

Penumbra Inc Așteptări

Obiectiv de preț

By TipRanks

6.63% sus

Prognoză pe 12 luni

Medie 338 USD  6.63%

Maxim 388 USD

Minim 266 USD

În baza a 14 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruPenumbra Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

14 ratings

13

Cumpărare

1

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

288.28 / 292.9394Suport & Rezistență

Termen scurt

Bearish Evidence

Termen mediu

Bullish Evidence

Termen lung

Weak Bullish Evidence

Sentiment

By Acuity

149 / 374 Clasament în Sănătate

Sentimentul știrilor

Neutral

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Penumbra Inc

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX Select, BENCHMARK, BMX96, BMX81, DDC, SENDit, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization Device, aspiration tubing, and aspiration pump under the Penumbra RED, JET, ACE, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other complex lesions, as well as Penumbra SMART COIL, a detachable coil to treat patients with a wide range of neurovascular lesions; and POD400 and PAC400 brands. In addition, the company provides peripheral embolization products, such as Ruby Coil System consisting of detachable coils for peripheral applications; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers an immersive 3D computer-based technology platform under the real immersive system brand; and neurosurgical tools, such as Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.
help-icon Live chat